Degenerative aortic stenosis

BMJ

Volumn 336, Issue 7643, 2008, Pages 550-555

  Ramaraj, Radhakrishnan ^a   Sorrell, Vincent L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITROPRUSSIDE SODIUM; ROSUVASTATIN;

AGING; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; BICUSPID AORTIC VALVE; CALCIFICATION; CARDIOVASCULAR RISK; CELL PROLIFERATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EXERCISE TEST; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HEMODYNAMIC STRESS; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID STORAGE; OSTEOBLAST; PATIENT EDUCATION; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; REVIEW; SURVIVAL; SYSTOLIC HEART MURMUR; TREATMENT CONTRAINDICATION;

AGE FACTORS; AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; PROGNOSIS;

EID: 40949136592     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39478.498819.AD     Document Type: Review

References (22)

1. Lung B, Baron G, Butchart EG, Delahaye F, GohLke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J 2003;24:1231-43.
2. Chambers J. Aortic stenosis. BMJ 2005;330:801-2.
3. Glader CA, Birgander LS, Söderberg S, Ildgruben HP, Saikku P, Waldenström A, et al. Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk marker for valvular aortic stenosis. Eur Heart J 2003;24:198-208.
4. Chan KL. Is aortic stenosis a preventable disease? J Am Coll Cardiol 2003;42:593-9.
5. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231
6. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68.
7. Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med 2002;162:2345-7.
8. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA, for the Doppler Quantification Task Force of the Nomenclature Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-84.
9. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5.
10. Jiménez-Candil J, Bermejo J, Yotti R, Cortina C, Moreno M, Cantalapiedra JL, et al. Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study. Heart 2005;91:1311-8.
11. Khot UN, Novaro GM, Popovic ZB, Mills RM, Thomas JD, Tuzcu EM, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003;348:1756-63.
12. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004;25:267-76.
13. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97.
14. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Gonçalves F, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-61.
15. Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation 1982;66:1105-10.
16. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35:747-56.
17. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J am Coll Cardiol 2006;47:1214-23.
18. Pereira JJ, Lauer MS, Bashir M, Afridi I, Blackstone EH, Stewart WJ, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 2002;39:1356-63.
19. Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, et al. Validation of European system for cardiac operative risk evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002;22:101-5.
20. Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199-205.
21. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302-8.
22. Monin JL, Quere JP, Monchi M, Petit H, Baleynaud S, Chauvel C, et al. Low-gradient aortic stenosis, operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003;108:319-24.